Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study.
Journal: The European respiratory journal
Published: December 15, 2022
Echocardiographic estimate of pulmonary artery pressure in sarcoidosis patients - real world data from a multi-national study.
Journal: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Published: February 15, 2021
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.
Journal: The New England journal of medicine
Published: January 13, 2021
Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry.
Journal: The European respiratory journal
Published: February 13, 2019
Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry.
Journal: Respiratory medicine
Published: February 08, 2018
Recommendations for the clinical management of patients receiving macitentan for pulmonary arterial hypertension (PAH): A Delphi consensus document.
Journal: Pulmonary circulation
Published: July 04, 2017
Pulmonary Hypertension in Sarcoidosis.
Journal: Clinics in chest medicine
Published: November 24, 2015
Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: October 10, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026